Datasheet of AZD2281(Olaparib)

Detailed information:
http://www.sun-shinechem.com/Details/AZD2281(Olaparib)/1624/763113-22-0.html

USD250.0/50.0mg;
Price USD400.0/100.0mg
Please send your email to sales@sun-shinechem.com for other package.

Product Name AZD2281(Olaparib)

1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-
Chemical Name
fluorobenzoyl]piperazine

Synonyms AZD-2281;AZD 2281

CAS No. 763113-22-0 Catalog No 92801

Molecular Weight 434.46

O
HN N
Molecular Formula C24H23FN4O3 N O

Other information N/A F O

Items Specifications Results

Appearance Off-white solid Complies

HNMR 400MHz,d6-DMSO Complies

Analysis
HPLC 98.0% Complies

Storage condition Kept under dry and cool condition

The above substance has been tested according to In house Standards, and it
Conclusion
meets requirements.

No.8 Rd, The Great Wall Park, Donghu High-Tech District 430074, Wuhan, China
Tel: 0086-27-59253327||Email:sales@sun-shinechem.com||Web:www.sun-shinechem.com
 Olaparib (AZD-2281, trade name Lynparza) is an FDA-approved targeted therapy for
cancer, developed by KuDOS Pharmaceuticals and later by AstraZeneca.
Description

No.8 Rd, The Great Wall Park, Donghu High-Tech District 430074, Wuhan, China
Tel: 0086-27-59253327||Email:sales@sun-shinechem.com||Web:www.sun-shinechem.com